Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111777637B details novel indole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions.
Patent CN114933570B reveals a mild copper-catalyzed route for 1,2,4-triazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Catalyst-free patent CN107033073B enables green high-yield synthesis. Delivers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced phosphine ligands with benzofuran structures for high-yield Suzuki-Miyaura reactions. Enhancing supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110467556B reveals a mild Ni(II) catalytic route for 3-substituted isoindolinones, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Patent CN115155658B details a novel one-pot synthesis for VAPOL-based selenium-sulfur catalysts, offering cost-effective solutions for asymmetric organic manufacturing.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Patent CN102382058A details a cost-effective Cu(II) catalyzed C-N coupling method for producing high-purity pharmaceutical intermediates with superior stability.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN114308121A discloses novel phosphine oxide catalysts enabling catalytic Mitsunobu reactions. Achieve high stereoselectivity, reduced waste, and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API manufacturing.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN118878543A reveals a novel synthesis for axial chiral compounds with high ee. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.